These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1313157

  • 1. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN, Gulati A, Rahmani NH.
    Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH, Gulati A, Bhargava HN.
    Pharmacology; 1991 Feb; 43(3):156-62. PubMed ID: 1663623
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
    Veeranna, Reddy PL, Bhargava HN.
    Eur J Pharmacol; 1993 Apr 22; 235(1):23-30. PubMed ID: 8390939
    [Abstract] [Full Text] [Related]

  • 4. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN, Gulati A, Ramarao P.
    J Pharmacol Exp Ther; 1989 Oct 22; 251(1):21-6. PubMed ID: 2552075
    [Abstract] [Full Text] [Related]

  • 5. Abstinence from U-50,488H, a kappa-opiate receptor agonist, decreases the binding of [3H]DPAT to 5-HT1A receptors in the hypothalamus of the rat.
    Reddy VP, Bhargava HN.
    Neuropharmacology; 1992 Dec 22; 31(12):1243-9. PubMed ID: 1470300
    [Abstract] [Full Text] [Related]

  • 6. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
    Bhargava HN, Gulati A, Ramarao P.
    Pharmacology; 1991 Dec 22; 42(3):121-7. PubMed ID: 1647533
    [Abstract] [Full Text] [Related]

  • 7. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
    Bhargava HN, Matwyshyn GA, Rattan AK, Koo KL, Tejwani GA.
    J Pharmacol Exp Ther; 1994 Feb 22; 268(2):856-61. PubMed ID: 8113998
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S, Bhargava HN.
    Neuropharmacology; 1987 Aug 22; 26(8):1141-6. PubMed ID: 2889163
    [Abstract] [Full Text] [Related]

  • 9. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
    Bhargava HN, Kumar S.
    Brain Res; 1997 Feb 28; 749(2):347-50. PubMed ID: 9138737
    [Abstract] [Full Text] [Related]

  • 10. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN, Ramarao P, Gulati A.
    Eur J Pharmacol; 1989 Mar 21; 162(2):257-64. PubMed ID: 2542058
    [Abstract] [Full Text] [Related]

  • 11. The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1-13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
    Bhargava HN, Matwyshyn GA, Rattan AK, Koo KL, Tejwani GA.
    Brain Res; 1993 Jan 08; 600(1):151-5. PubMed ID: 8093675
    [Abstract] [Full Text] [Related]

  • 12. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
    Bhargava HN, Matwyshyn GA, Gudehithlu KP.
    Pharmacology; 1995 Nov 08; 51(5):323-30. PubMed ID: 8584584
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
    Bhargava HN, Gulati A, Ramarao P.
    Biochem Pharmacol; 1991 Jun 21; 42(1):25-9. PubMed ID: 1648922
    [Abstract] [Full Text] [Related]

  • 14. Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats.
    Tejwani GA, Rattan AK, Koo KL, Matwyshyn GA, Bhargava HN.
    Pharmacology; 1994 Apr 21; 48(4):216-25. PubMed ID: 8177908
    [Abstract] [Full Text] [Related]

  • 15. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL, Veeranna, Matwyshyn GA, Thorat SN, Bhargava HN.
    Gen Pharmacol; 1994 Mar 21; 25(2):355-61. PubMed ID: 8026736
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
    Thorat SN, Veeranna, Reddy PL, Bhargava HN.
    Brain Res; 1993 Jul 02; 615(2):191-8. PubMed ID: 8395957
    [Abstract] [Full Text] [Related]

  • 17. Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat.
    Gulati A, Ramarao P, Bhargava HN.
    Pharmacology; 1989 Jul 02; 39(3):145-53. PubMed ID: 2587620
    [Abstract] [Full Text] [Related]

  • 18. Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.
    Bhargava HN, Matwyshyn GA, Reddy PL, Veeranna.
    Pharmacol Biochem Behav; 1994 May 02; 48(1):87-91. PubMed ID: 8029307
    [Abstract] [Full Text] [Related]

  • 19. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats.
    Bhargava HN, Das S, Bansinath M.
    Peptides; 1987 May 02; 8(2):231-5. PubMed ID: 3035513
    [Abstract] [Full Text] [Related]

  • 20. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN, Gulati A.
    Peptides; 1988 May 02; 9(4):771-5. PubMed ID: 2852360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.